Domenica Lorusso, MD, PhD, is a gynaecologic oncologist working at the Gynaecology Oncology Unit of Fondazione IRCCS National Cancer Institute of Milan. She obtained her medical degree from the Catholic University of Rome in 1995 and her PhD in obstetrics and gynaecology from the University of Parma in 2003.
Dr. Lorusso has been involved in gynaecological oncology research for more than 10 years and has conducted or participated in approximately 50 phase I-IV clinical trials in gynaecological malignancies. She is responsible of the Clinical Trials Committee of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynaecological Malignancies) Group, which includes more than 150 Italian centres involved in gynaecological oncology research.
Dr. Lorusso is an active member, and past chair of the Endometrial Cancer Committee, of the Gynaecological Cancer Intergroup. This group includes 23 international research groups from all over the world and aims to promote and conduct high quality clinical trials to improve outcomes for women with gynaecological cancers.
At present, Dr. Lorusso is part of the board of Directors of GCIG. Dr Lorusso is also active member of ENGOT (European Network of Gynaecological Oncological Trial groups) an international organisation which coordinates and promotes clinical trials within Europe for patients with gynaecological cancers. She has also co-authored more than 100 international oncology publications. She is author of national guidelines on treatment of ovarian, cervical and endometrial cancer, and international guidelines on treatment of rare ovarian tumours and vulvar cancer.
Dr Lorusso’s key goals are to promote clinical research, international trial collaborations and educations. She has broad experience in clinical trial protocol development, conduct and regulations.
As of 2017, Dr. Lorusso is a member of the ESMO Gynaecological Cancer Faculty Group, and Editorial Board member of Annals of Oncology.
ESMO 2017 Congress
"The ESMO 2017 Congress, for the first time in partnership with the European Association for Cancer Research (EACR), aims to bring cancer researchers and clinicians together to stimulate collaboration and create a real and direct connection, from the laboratory to the bedside and back. We hope this collaboration will translate into a unique cancer congress in Europe with huge scientific reach and the true potential to improve the lives of cancer patients.
The ESMO Congress is the most influential annual meeting for oncology professionals in Europe. Experienced oncologists treating a wide range of diseases and cancer researchers will work together to provide an update on the latest clinical data in oncology and how to integrate the latest translational findings into your clinical routine"
Domenica Lorusso was the Gynaecological Cancers Track Chair of the ESMO 2017 Congress, which took place in Madrid, Spain (8-12 September 2017).